{"product_id":"the-worldwide-market-for-point-of-care-poc-diagnostic-tests-10th-edition","title":"The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition","description":"\u003cp\u003eThe Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition\u003cbr\u003e\nNOW IN ITS TENTH EDITION!\u003c\/p\u003e \n\n\u003cp\u003eWhile tests run on lab-based analyzers in hospitals and reference labs remain the bedrock of IVD revenues, point of care has always been seen as the growth area.  For as long as Kalorama Information has covered point of care diagnostics, and this now spans 2 decades, point of care tests are the opportunity area.  Point of care as implied in the name is defined as tests that can be meaningful in a provider visit, or in the patients home.\u003c\/p\u003e  \n\n\u003cp\u003eHow can diagnostics promote wellness? How can diagnostics improve patient-provider encounters?  How can tests promote better selection and stewardship of drugs?  How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled?  The answers to these questions in many ways rely on the success of point-of-care solutions.\u003c\/p\u003e\n\n\u003cp\u003eAnd because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests.  The tests covered in this report tend to grow at higher rates than overall IVD market.\u003c\/p\u003e  \n\n\u003cp\u003eEnhanced Segmentation - Many Reports in One\u003c\/p\u003e\n\n\u003cp\u003eHere are just some of the areas covered in this report    Glucose    Coagulation    CRP    Other Cardiac Markers    Coagulation    Colon Cancer    Pregnancy \/ Fertility    Drugs of Abuse    hbA1c    Cholesterol     HIV    COVID-19     Other Infectious Disease    Critical Care TestsThese are detailed with market sizing and forecast in this report.\u003c\/p\u003e \n\n\u003cp\u003eAs discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home.   \u003cbr\u003e\nVenue Market Analysis\u003cbr\u003e\nPOC tests are performed in a wide range of geographical locations such as:    Hospital departments such as emergency departments, operating rooms, intensive care units, and others    Physicians’ offices    Hospital clinics    Retail clinics    Pharmacies    Homes – With testing performed by patients, visiting nurses, or other caregivers    Nursing homesPOC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.\u003c\/p\u003e\n\n\u003cp\u003eRegional Coverage\u003c\/p\u003e\n\n\u003cp\u003ePOC is an international market and Kalorama reflects this with regional coverage.\u003c\/p\u003e  \n\n\u003cp\u003eAnalysis is anchored by:    Europe    Japan    United States    Rest of WorldHowever other countries and regions discussed in the report include:    Australia     Canada     China    France    Germany    India    Italy    South Korea    Spain    Sweden    Switzerland    Latin America    Middle EastCorporate Profiles\u003c\/p\u003e\n\n\u003cp\u003eMoreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use.  At the same time, more decentralized test venues invest in non-waived rapid tests and instruments.  POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care.  New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.\u003c\/p\u003e\n\n\u003cp\u003eThis report breaks out point of care testing by segment.\u003c\/p\u003e\n\n\u003cp\u003eAmong the top and\/or innovative competitors discussed within Corporate Profiles are:    1 Step Detect Associates, Llc    Abbott Laboratories    Abingdon Health Ltd.    Accessbio, Inc.    Accubiotech Co, Ltd.    Acon Laboratories, Inc    Aerscher Diagnostics, Llc    Alfa Scientific Designs, Inc    American Bio Medica Corporation    Arkray, Inc.    Artron Laboratories, Inc    Ascensia Diabetes Care Holdings Ag    Atlas Link Biotech Co., Ltd    Autobio Diagnostics Co., Ltd    Beckman Coulter, Inc    Becton Dickinson (Bd)    Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.    Bhat Bio-Tech India Private Ltd. (Bbi)    Binx Health    Biolytical Laboratories    Biomedomics, Inc    Biomeme, Inc    Biomerica, Inc.    Biomerieux Sa    Bio-Rad Laboratories Inc.    Biosensia Ltd.    Biotron Diagnostics, Inc.    Boditech Med Inc    Boson Biotech Co. Ltd    Btnx Inc.    Calypte Biomedical Corporation    Cepheid, Inc    Chembio Diagnostics, Inc.    Church \u0026amp; Dwight Co. Inc    Clarity Diagnostics, Llc    Confirm Biosciences    Ctk Biotech, Inc.    Cue Health    Danaher Corporation    Dexcom, Inc    Dialab Gmbh    Diasys Diagnostic Systems Gmbh    Diazyme Laboratories, Inc.    Dna Electronics Ltd. (Dnae)    Dr. Fooke-Achterrath Laboratorien Gmbh    Dxgen Corp.    Eiken Chemical Co Ltd.    Ekf Diagnostics Holdings Plc    Elitechgroup S.A.S.    Enterix, Inc. (Clinical Genomics)    Eurobio Scientific    Everlywell    Exact Sciences    Ey Laboratories    First Check Diagnostics Llc    Genbio    Genedrive Plc    Getein Biotech Inc.    Glysby Diagnostics    Helena Laboratories    Hemosure, Inc.    Horiba, Ltd.    Immune Iq    Immunosciences Lab, Inc.    Immunostics, Inc    Jal Innovation Pte Ltd    Jant Pharmacal Corporation    J. Mitra \u0026amp; Co Pvt. Ltd    Lamdagen Corporation    Lifescan, Inc    Lifesign, Llc    Lightdeck Diagnostics    Lumiradx Uk Limited    Macherey-Nagel Gmbh \u0026amp; Co. Kg    Medix Biochemica    Medmira, Inc    Medtronic, Inc.    Menarini Diagnostics Srl.    Meridian Bioscience, Inc    Mico Biomed Usa    Nano-Ditech Corporation    Ng Biotech    Noble Medical, Inc    Nova Biomedical Corp.    Oasis Diagnostics Corporation    Operon S.A.    Opko Health, Inc    Orasure Technologies, Inc.    Polymedco, Inc    Polymer Technologies, Inc (Pts Diagnostics)    Preventis Gmbh    Princeton Biomeditech Corporation    Quantumdx Group Limited    Quidelortho Corporation    Radiometer Medical A\/S    Randox Laboratories Limited    Response Biomedical Corp    Reszon Diagnostics International Sdn. Bhd.    Rheonix, Inc    Roche Diagnostic Corporation    Savyon Diagnostics    Sekisui Diagnostics Llc    Siemens Healthineers Gmbh    Sysmex Corporation    Techlab, Inc.    Trinity Biotech Plc    Trividia Health    Tulip Diagnostics Ltd (Tulip Group)    Vedalab    Veredus Laboratories Pte Ltd    WerfenScope and Methodology\u003c\/p\u003e\n\n\u003cp\u003eThe  geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers.  Additionally, key company profiles are included.\u003c\/p\u003e\n\n\u003cp\u003eAll market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services.  The base year for data was 2022, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2022-2026 periods for each segment covered.  Competitive analysis is provided for the year 2022 along with regional breakdowns.  The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"April, 2023 \/ 600 Pages \/ MCW16236540","offer_id":47652181442866,"sku":null,"price":7200.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/the-worldwide-market-for-point-of-care-poc-diagnostic-tests-10th-edition","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}